• Impact of Comorbidities on Medication Adherence In Hypertensive Patients

    Nov 1, 2016, 00:00

  • Cost Utility Analysis of Monitoring Osteoporosis Fracture Risk By A Circulating Microrna Based Strategy Compared to Standard Measure and No Monitoring

    Nov 1, 2016, 00:00

  • Budget Impact of Apremilast for Moderate to Severe Plaque Psoriasis in the UK

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab in Patients with Advanced or Metastatic Renal Cell Carcinoma in Portugal

    Nov 1, 2016, 00:00

  • Treatment Cost of Post Myocardial Infarction- An Analysis in Heart Institute in Ho Chi Minh City, Vietnam

    Nov 1, 2016, 00:00

  • Potential Impact of The Cancer Drugs Fund Reform on Orphan Cancers

    Nov 1, 2016, 00:00

  • The Future Of Uk Drug Pricing- The 2014 Pprs (An Interim Review)

    Nov 1, 2016, 00:00

  • Current Reimbursement Situation of Advanced Therapy Medicinal Products (ATMP) in Germany- Which Strategy to Secure Adequate Funding?

    Nov 1, 2016, 00:00

  • Systematic Review of Psychometric Properties of The EQ-5D Questionnaires In Patients with Hematologic Malignant Neoplasms

    Nov 1, 2016, 00:00

  • Predictors of PD-L1 Testing in Non-Small Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Comorbidity-Based Eq-5d Scores Of Primary Care Patients In Finland, Their Potential To Benefit And Unmet Medical Need

    Nov 1, 2016, 00:00

  • A Systematic Review of Cardiovascular Event Utilities in Asia

    Nov 1, 2016, 00:00

  • Use of Net Monetary Benefit Analysis to Comprehensively Understand the Value of Innovative Treatments

    Nov 1, 2016, 00:00

  • Outcomes From Homeopathic Prescribing in Secondary Care Homeopathic Hospital- A Prospective Study

    Nov 1, 2016, 00:00

  • A Nationwide Survey on Infection Control Activities Within Hospitals Allowed to Implement Preferential Infection Prevention Countermeasure Fee in Japan

    Nov 1, 2016, 00:00

  • 7th AP - FDS Financial Disclosure Statements

    Nov 1, 2016, 00:00

  • Evaluation of Potential Drug-Drug Interactions among the People Living with HIV with Highly Active Antiretroviral Therapy at Kasturba Hospital

    Nov 1, 2016, 00:00

  • Methods For Analyzing Patient-Reported Outcomes In Oncology Trials

    Nov 1, 2016, 00:00

  • Evaluation of Adherence To Management Guidelines of Asthmatic Patients In Greece And Measures To Implement To Achieve Asthma Control

    Nov 1, 2016, 00:00

  • The Cost of Glycaemic Target Achievement with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU) in the UK

    Nov 1, 2016, 00:00

  • The Factors Related with Patient Experience of Medication- A Multilevel Analysis

    Nov 1, 2016, 00:00

  • Euroqol To Assess The Quality of Life with Smartphone

    Nov 1, 2016, 00:00

  • A Multi-Criteria Decision Analysis Approach within The Diabetic Macular Edema Field- The Experience of 3 Italian Regions

    Nov 1, 2016, 00:00

  • Three Methods for Measuring Productivity Losses Due to Health Related Presenteeism in Economic Evaluations

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Interferon-Gamma Release Assay for Tuberculosis Screening of Mental Patients with Tobacco Smoking

    Nov 1, 2016, 00:00

  • When Is The Use Of A Systematic Literature Review Appropriate? A Comparison Of Systematic, Rapid, And Scoping Reviews And Their Application To The Hta Process

    Nov 1, 2016, 00:00

  • An Updated Cost-Effectiveness Analysis of Synflorix Universal Mass Vaccination Implementation in New Zealand

    Nov 1, 2016, 00:00

  • Evaluation of The Comparability of Scores From Cat and Short-Form

    Nov 1, 2016, 00:00

  • High Risk of Depression In Patients with Heart Failure in Germany

    Nov 1, 2016, 00:00

  • Patient Characteristics And Health Outcomes In Adults Diagnosed With Marfan Syndrome In The United States

    Nov 1, 2016, 00:00

  • Infertility Treatment Of Women Over Age 35 In Brazil- An Economic Evaluation Of Recombinant VS. Urinary Gonadotropins

    Nov 1, 2016, 00:00

  • Use, Belief, and Risk Awerness to Medication Among Pregnant Women Attending Antenatal Care Unit at University of Gondar Teaching Hospital, Northwestethiopia- Crosssectional Study

    Nov 1, 2016, 00:00

  • Patient Centricity – Patient Related Programs In The German Healthcare Environment

    Nov 1, 2016, 00:00

  • Cancer Drugs in Europe- A Comparison of HTA Processes and Decisions for New and Innovative Oncology Therapies in France, Germany and The UK – An Analysis Using The Prismaccess Database

    Nov 1, 2016, 00:00

  • Assessment of Health Related Quality of Life of Hospital Admitted Patients in Tertiary Care Hospitals Quetta by Using SF-12 Questionnaire

    Nov 1, 2016, 00:00

  • Precision Heor- Using Big Data to Develop a Personalized Modeling Framework

    Nov 1, 2016, 00:00

  • Healthcare Cost of Patients Presenting with Peripheral Artery Disease (PAD)- An Analysis Using A Claims Database in France

    Nov 1, 2016, 00:00

  • Valuing Informal Care- Making Normative Judgments in A Positive Milieu

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban and Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement in China

    Nov 1, 2016, 00:00

  • Isolation and Antibiotic Susceptibility of Pathogenic Microorganisms Among UTI Patients in Tertiary Care Hospital, Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax) For Patients With Genotype 4 Hcv In Greece

    Nov 1, 2016, 00:00

  • 5-Year Overall Survival and Progression-Free Survival in Multiple Myeloma by Line of Treatment from the French Hematologic Malignancy Registry

    Nov 1, 2016, 00:00

  • Health Economics Analysis Plans- Where Are We Now?

    Nov 1, 2016, 00:00

  • Lifestyle Beliefs Of 672 Patients With Rheumatoid Arthritis Or Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Chilean National Health Fund (Fonasa)

    Nov 1, 2016, 00:00

  • Regional Time To Market Of Innovative Drugs In Italy

    Nov 1, 2016, 00:00

  • Meta-Analysis of The Effectiveness on Peginterferon for Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Healthcare Pathway and Costs Analysis in Patients with Metastatic Prostate Cancer (MPC)

    Nov 1, 2016, 00:00

  • Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion

    Nov 1, 2016, 00:00

  • Prevalence, Pharmaceutical Expenditures and Patient's Factors of High-Risk Medication used among Elderly Inpatients at a District Hospital in the South of Thailand

    Nov 1, 2016, 00:00

  • Estimating Utilities for Liver Diseases Using Standard Gamble Method

    Nov 1, 2016, 00:00

  • Biologics use in Crohn’s Disease in France

    Nov 1, 2016, 00:00

  • Health-Economic Evaluation of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Treatment of Chronic Genotype 1 Hcv Infection in Germany

    Nov 1, 2016, 00:00

  • Validation of Model-Simulated Clinical Outcomes of Antiplatelet Therapies in Patients with Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/ Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in The Czech Republic- Analysis Based on Patient Characteristics From Randomized Clinical Trial and Local Registries

    Nov 1, 2016, 00:00

  • comparative Evaluation of Safety, Efficacy and Cognitive Profile of Amisulpride and Olanzapine in Schizophrenia Patients- A Prospective Study

    Nov 1, 2016, 00:00

  • Challenging Model Complexity; A Simpler Approach For Developing Markets

    Nov 1, 2016, 00:00

  • Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for the Treatment of Type 2 Diabetes Mellitus in the Spanish Setting

    Nov 1, 2016, 00:00

  • Temporal Trends In Transthyretin Familial Amyloid Polyneuropathy Natural Survival Over A Century

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bariatric Surgery For The Treatment of Morbid Obesity Patients Compared With Conservative Management In Spain

    Nov 1, 2016, 00:00

  • Cost-of-Illness of Acromegaly in Sweden – A Register-Linkage Population-Based Study

    Nov 1, 2016, 00:00

  • Market Exclusivity Periods And Patent Challenges In Pharmaceuticals In South Korea

    Nov 1, 2016, 00:00

  • Comparing Different Data on Disease Burden In Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Eficacy And Satefy of Methylprednisolone In The Treatment of Idiopathic Thrombocytopenic Purpura

    Nov 1, 2016, 00:00

  • Health Utility Measured with EQ-5D-5L in Japanese Patients Undergoing Hemodialysis

    Nov 1, 2016, 00:00

  • Health State Utilities in Chronic Heart Failure in The UK- A Systematic Review

    Nov 1, 2016, 00:00

  • The Study of Drug Price Comprison Between China and 14 Other Countries

    Nov 1, 2016, 00:00

  • Data Mining Used To Characterize Discordance In Gastric Cancers HER2 Status Determination To Help For A Better Treatment Decision

    Nov 1, 2016, 00:00

  • An Anchor-Based Approach to Define an Impaired Day in Migraine Patients Utilizing the Migraine Physical Function Impact Diary

    Nov 1, 2016, 00:00

  • Psychometric Analyses of Clinical Outcome Assessment (Coa) Questionnaires Designed to Evaluate Satisfaction with Pharmacological Stress Agents (Psas) Used in Echocardiography

    Nov 1, 2016, 00:00

  • Mapping The Involvement Of Eunethta Participants In Eu Research Projects

    Nov 1, 2016, 00:00

  • Developing A Conceptual Framework and a Tool for Measuring Absorptive Capacity in Pharmaceutical Companies

    Nov 1, 2016, 00:00

  • Cumulative Cost of Treatment with ILUVIEN (Fluocinolone Acetonide [FAC]) Versus the Current Standard of Care in the Treatment of Visual Impairment Due to Diabetic Macular Oedema (DMO) in Phakic Eyes Over a 3 Year Period- An Analysis from a ...

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Non-Invasive Prenatal Testing for Down's Syndrome in China

    Nov 1, 2016, 00:00

  • Do First-In-Class Drugs Offer Larger Incremental Health Gains Than Next-In-Class Drugs?

    Nov 1, 2016, 00:00

  • Factors Influencing Door-To-Doctor Time In An Emergency Department- Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Assessment Of Patient Need During Hospitalization By Using Neq (Need Evaluation Questionnaire) In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From A Survey of Clinicians in Taiwan

    Nov 1, 2016, 00:00

  • Analyzing The Revenues And Expenditures Of The Hungarian Health Insurance Fund Between 1993-2015

    Nov 1, 2016, 00:00

  • Cochlear Implant In Prelingually Deafened Oralist Adults- Speech Perception Outcome, Subjective Benefits And Quality Of Life Improvement

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Grazoprevir / Elbasvir In Patients With Chronic Hepatitis C Virus

    Nov 1, 2016, 00:00

  • Market Access Pathways for Drugs with EMA Conditional Approval

    Nov 1, 2016, 00:00

  • Socio-economic status and self-rated health- are they good predictors of income? An analysis of survey panel data from turkey

    Nov 1, 2016, 00:00

  • Compiling and Reconciling Evidence to Assign Risk of Febrile Neutropenia to Chemotherapy Regimens

    Nov 1, 2016, 00:00

  • Assessment of Clinical Value in Oncology- Comparative Analysis of Value Frameworks and HTAS

    Nov 1, 2016, 00:00

  • Direct Cost Estimation of Psoriatic Arthritis Treatment In Turkey- Results From A Delphi Panel

    Nov 1, 2016, 00:00

  • Healthcare Resource use of Patients Newly Diagnosed with Multiple Sclerosis Initiating Oral or Self-Injectable Disease-Modifying Drugs- A Large, Nationwide Analysis of US Electronic Health Record Data

    Nov 1, 2016, 00:00

  • English CCG Formularies- Resources And Priorities

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Standard Care with Serelaxin in Treatment of Patients with Acute Decompensated Heart Failure

    Nov 1, 2016, 00:00

  • Schools' Perspective on Promoting Rational use of Antibiotics in New Delhi, India – A Qualitative Study

    Nov 1, 2016, 00:00

  • Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumat ...

    Nov 1, 2016, 00:00

  • Exploring Pharmacist's Role In Palliative Care- A Qualitative Study

    Nov 1, 2016, 00:00

  • The Burden of Parkinson's Disease(Pd) in Japan

    Nov 1, 2016, 00:00

  • Caregiver Burden and Quality of Life of Informal Caregivers of Stroke Patients- A Prospective Study

    Nov 1, 2016, 00:00

  • Treatment Patterns of Patients Treated With Ranibizumab or Aflibercept For The Management of Neovascular Age-Related Macular Degeneration- A Retrospective Cohort Study in Australia

    Nov 1, 2016, 00:00

  • Susceptibility Pattern of Pseudomonas Aeruginosa Isolates to Carbapenem Antibiotics

    Nov 1, 2016, 00:00

  • Structured Review of Health Economic Models in Asthma

    Nov 1, 2016, 00:00

  • Patient Counseling By A Specialty Pharmacist Increases Pain Medication Adherence And Persistency

    Nov 1, 2016, 00:00

  • Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For Turkey

    Nov 1, 2016, 00:00

  • Prescribing Patterns of Psychostimulants, Agents Used For ADHD And Nootropics

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Nilotinib Versus Imatinib in Newly Diagnosed Chronic Myeloid Leukemia from the Health Insurance Perspective in Egypt

    Nov 1, 2016, 00:00

  • Recommendations on Cognitive Debrief and Usability Studies for Instrument Migration from Paper to Electronic Modalities Based on A Qualitative Synthesis of Validation Studies

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Total Knee Replacement in Czech Republic

    Nov 1, 2016, 00:00

  • Evaluation Of Clinical And Economic Impact Of Drug Related Problems In Elderly Patients At Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Sunitinib Dosing Schedules in The Management of Metastatic Renal Cell Carcinoma- A Meta-Analysis

    Nov 1, 2016, 00:00

  • Systematic Review of Quality of Life Measurement Instruments and Response Criteria Among Patients with Myelodysplastic Syndromes

    Nov 1, 2016, 00:00

  • The Risks of Using Chinese Medications Associated with Cardiovascular Disease, Diabetes Mellitus, and Chronic Kidney Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Prophylaxis Compared to On-Demand Treatment in Severe Haemophilia a. Systematic Review

    Nov 1, 2016, 00:00

  • Prevalence of Shisha Smoking among Adult Male Cigarette Smokers of Multan, Pakistan

    Nov 1, 2016, 00:00

  • Quasi-Experimental Methods For Real World Data

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Dabigatran vs. Rivaroxaban and Vitamin K Antagonists in Elderly Patients with Nonvalvular Atrial Fibrillation in Spain

    Nov 1, 2016, 00:00

  • Variation in the Number and Type of Heart Valve Procedures Performed in the UK – Is Patient Access Equitable?

    Nov 1, 2016, 00:00

  • Cost-Analysis of Heart Valve Implantations, Complications and Follow-UP Based on National Health Insurers Claims Data in The Netherlands

    Nov 1, 2016, 00:00

  • What Impact is the Evolving Health Care Landscape Having on Access to Innovative Medicines in China?

    Nov 1, 2016, 00:00

  • Impact Of The Introduction Of New Branded Generic Equivalents On The Prescribing Patterns Of Anti-Dementia Medication

    Nov 1, 2016, 00:00

  • Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

    Nov 1, 2016, 00:00

  • Is The Institute Of Clinical And Economic Review (Icer) Set Up For Success? A Comparison Between Icer And Ex-U.S. Hta Agencies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treatment of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO)

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis in Postoperative Pain Management After Non-Cardiac Major Surgeries in China- Parecoxib Versus Nonselective Nonsteroidal Anti-Inflammatory Drugs and Tramadol

    Nov 1, 2016, 00:00

  • A Review Of Patient-Reported Outcome Measures To Assess Infertility-Related Quality Of Life

    Nov 1, 2016, 00:00

  • Estimating the Utility Associated with Mode of Treatment Administration in Gaucher Disease

    Nov 1, 2016, 00:00

  • Prevalence of Obesity And Overweight And Associated Factors Among Financial Institution Workers In Accra Metropolis, Ghana- A Case Control Study

    Nov 1, 2016, 00:00

  • Innovative Contracting in Spain (2010-2016). Getting More "IN"

    Nov 1, 2016, 00:00

  • Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)

    Nov 1, 2016, 00:00

  • Translation, Adaptation And Validation Of The Diabetes Distress Scale For Indonesian Diabetic Outpatients With Various Types Of Complications

    Nov 1, 2016, 00:00

  • Using Simulated Individual Patient Data (IPD) From Published Registry and Ipd From The Seer-Medicare Registry To Extrapolate Results From Randomised Clinical Trials (RCTS) in Metastatic Melanoma

    Nov 1, 2016, 00:00

  • Price Negotiations for Orphan Drugs in Germany

    Nov 1, 2016, 00:00

  • ND1 Burden And Work Productivity Loss Impairment From Providing Care To Alzheimer's Disease Patients

    Nov 1, 2016, 00:00

  • Overcoming Hta Hurdles Through Early Collaboration Between Pharmaceutical Companies And Companion Diagnostic Companies

    Nov 1, 2016, 00:00

  • Development Of A Search Engine For The Medline Database With Search Results Ranking From The Perspective Of Evidence-Based Medicine

    Nov 1, 2016, 00:00

  • Assessing The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In France, Italy And Sweden

    Nov 1, 2016, 00:00

  • Impact Of Changes In The Methodology Of External Price Referencing On Prices

    Nov 1, 2016, 00:00

  • The Risk of Falls and Fractures Among Those with Overactive Bladder- A Systematic Review

    Nov 1, 2016, 00:00

  • Historical and Future Oral Lipid Modifying Therapy Market Size in Top Five European Countries

    Nov 1, 2016, 00:00

  • Dengue Negatively Affects Gdp And Federal Revenues In Endemic Areas Of Mexico

    Nov 1, 2016, 00:00

  • How To Ensure An Efficient Resource Allocation For The Treatment of Chronic Myeloid Leukemia

    Nov 1, 2016, 00:00

  • The Chickenpox Complications and Financial Burden in Healthy Children and with Underlying a Comorbidity During the Pre Vaccine and Post Vaccine Era in a University Hospital

    Nov 1, 2016, 00:00

  • Economic Impact of Drug Addiction Interventions in Adult Population- The Peru Case

    Nov 1, 2016, 00:00

  • Developing a Comprehensive, Culturally Sensitive Conceptual Framework of Health Domains in Singapore

    Nov 1, 2016, 00:00

  • A Qualitative Comparison of German and UK Health Technology Assessments- Vedolizumab Case Study

    Nov 1, 2016, 00:00

  • Clinical and Comparative Effectiveness of Telemonitoring Intervention Versus Usual Care For Hypertension- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Products Outside the General Reimbursement Systems – A Swedish and Norwegian Comparison

    Nov 1, 2016, 00:00

  • The Clinical, Functional and Economic Benefits of Physical Rehabilitation- A Systematic Review

    Nov 1, 2016, 00:00

  • Pricing and Market Access of Orphan Drugs in China- Analysis of National and Provincial Policy and the Associated Impact on Coverage

    Nov 1, 2016, 00:00

  • Systematic Review of Cost Effectiveness Analysis of Ivabradine in Heart Failure

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Diagnostics of Tuberculosis Infection in The Russian Federation with The Use of Tuberculous Recombinant Allergen

    Nov 1, 2016, 00:00

  • Gefitinib, Erlotinib and Chemotherapy as Second-Line Treatment for Patient with Advanced Non-Small Lung Cancer (NSCLC)

    Nov 1, 2016, 00:00

  • Treatment Patterns, Biomarker Testing (BMX) Practices and Healthcare Resource Use (HCRU) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in Taiwan

    Nov 1, 2016, 00:00

  • Psychometric Testing Of The Finnish Version Of The Prosthesis Evaluation Questionnaire

    Nov 1, 2016, 00:00

  • Adding A Decision Aid to Asthma Education- Impact on Decisional Conflict and Appropriate Medication Usage

    Nov 1, 2016, 00:00

  • A Qualitative Study Evaluating The Attitude and Perception of Physician and Pharmacist Towards Pharmacovigilance in Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • Market Access In The Context Of Economic Crisis- Insights From Several European Countries

    Nov 1, 2016, 00:00

  • Does Hospital At Home Need A New Funding For Oral Anti-Cancer Drugs ?

    Nov 1, 2016, 00:00

  • Three Year Treatment Patterns of Ranibizumab and Aflibercept for The Management of Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in The USA

    Nov 1, 2016, 00:00

  • Could European Regulators Contribute to Drug Budget Containment?

    Nov 1, 2016, 00:00

  • Data Imputation for Missing Values in a Claim-Based Administrative Database- Comparison of Imputatation Approaches

    Nov 1, 2016, 00:00

  • Pragmatic Review of Clinical Efficacy, Safety and Health Care Related Quality of Life (HRQOL) For Transtuzumab Monotherapy in Metastatic HER2+ Breast Cancer (MBC)

    Nov 1, 2016, 00:00

  • Obstacles for Adoption of Value Added Medicines- Call for Policy Changes for Value Recognition of Repurposed Medicines

    Nov 1, 2016, 00:00

  • Economic Study of Non-Pharmacological and Pharmacological Treatment for Osteoporosis Vertebral Fracture and Bone Events in Oncology Patients in a Health Insurance Provider in a Latin America Country

    Nov 1, 2016, 00:00

  • Teledermoscopy as a Referral Method in Australia- A Decision Analytic Model

    Nov 1, 2016, 00:00

  • MD1 Medical Devices- Timely Access and Reimbursement - Can National Health Technology Assessment Bodies Be Part of the Solution?

    Nov 1, 2016, 00:00

  • Determination of Predictors of Prolonged Hospitalization among Dengue Patients Attending Tertiary Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Economic Burden of Antibiotic-Resistant Nosocomial Gram-Negative Infections in Singapore Hospitals

    Nov 1, 2016, 00:00

  • Societal Impact of One-Time Screening for Diabetes at Age 30 in the Indian Population- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Designing A Discrete Choice Experiment To Measure Patient Preferences And Willingness-To-Pay For Targeted Therapies For Colorectal Cancer In Singapore

    Nov 1, 2016, 00:00

  • Challenges in Economic Evaluations Conducted Alongside Clinical Trials of Schizophrenia- The Case of the Actions Study

    Nov 1, 2016, 00:00

  • Real-World Comparing Intravenous Busulfan to Total Body Irradiation in Hematopoietic Stem Cell Transplantation aith a Japanese Diagnosis Procedure Combination (DPC) Database

    Nov 1, 2016, 00:00

  • Assessment of Secondary Recurrence of Stroke in Aspirin-Clopidogrel Combination Therapy and Aspirin Monotherapy in Transient Ischemic Attack Patients in South India- A Comparative Study

    Nov 1, 2016, 00:00

  • Applying The Accepted Techniques of Indirect Treatment Comparison to Meet Payer Needs For Brivaracetam Versus Adjunctive Antiepileptic Medications for The Treatment of Focal Seizures In Adult Patients. Do they reflect the need for individua ...

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Reslizumab and Mepolizumab For The Treatment of Asthma- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Treatment Persistence with Golimumab in France

    Nov 1, 2016, 00:00

  • The Follow-Up and Utilization of Drug Treatment for Chronic Hbv/Hcv Patients with Major Psychiatric Diseases in Taiwan

    Nov 1, 2016, 00:00

  • Marketing Situation and Medical Reform Policy Analysis of Oral Hypoglycemic Drugs in China

    Nov 1, 2016, 00:00

  • Systematic Literature Review (SLR) of Clinical Evidence Available To Estimate The Cost-Effectiveness of Factor Ix (FIX) Replacement Therapy In Haemophilia B (HB)

    Nov 1, 2016, 00:00

  • Masters Degrees For Health Economists- Investigating And Evaluating Their Content

    Nov 1, 2016, 00:00

  • Cost Of Total Parenteral Nutrition Services At Ministery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Influence of Cochrane Evidence on Medical Policies of Oncology Drugs in the United States

    Nov 1, 2016, 00:00

  • Complications And Health Care Costs Of Influenza In Germany- A Retrospective Claims Data Analysis

    Nov 1, 2016, 00:00

  • Criteria Used by German Pulmonologists for the Selection of an Inhaler

    Nov 1, 2016, 00:00

  • Evaluating Patient Access to Targeted Therapeutics Amidst the Evolving Singaporean Health Care Landscape

    Nov 1, 2016, 00:00

  • Real-Life Persistence of Budesonide/Formoterol Spiromax for The Management of Asthma and COPD in The UK

    Nov 1, 2016, 00:00

  • Edss State and Health Utility Measured by Eq5d in Relapsing-Remitting Multiple Sclerosis (Rrms)

    Nov 1, 2016, 00:00

  • Cancer Concerns From US Medical And Pharmacy Directors 2016

    Nov 1, 2016, 00:00

  • The Impact of Different Gastrointestinal Symptoms on The Well-Being of Affected Patients - Utility Weights for The Gastrointestinal Symptom Score (GIS)

    Nov 1, 2016, 00:00

  • Nice Collateral Effect- What Is The Influence Of Nice On Other Hta Bodies?

    Nov 1, 2016, 00:00

  • Patients' Acceptance And Adherence Of Their Medication- Results From A European Multi-Disease Study With Online Patient Community

    Nov 1, 2016, 00:00

  • Insights Into Early Stages of Alzheimer's Disease Using Claims Data

    Nov 1, 2016, 00:00

  • Impact Of Post-Inscription Studies On Reassessment In Fran A Case Study On Orphan Drugs

    Nov 1, 2016, 00:00

  • Historical Trends and Correlations of Pulmonary Embolism in Taiwan

    Nov 1, 2016, 00:00

  • Racial Differences in Cardiovascular Disease Prevalence and Mortality In the United States

    Nov 1, 2016, 00:00

  • Asians' Mental Health Status in a u.s. Midwestern metropolis, 2004 -2013

    Nov 1, 2016, 00:00

  • Developing a Geospatial Web and Mobile Application to Improve Expanded Program on Immunization in Ghana- A Mhealth Technology Novelty, 2015

    Nov 1, 2016, 00:00

  • Acupuncture Treatment for Neuropathic Pain in Spinal Cord Injury

    Nov 1, 2016, 00:00

  • Economic Benefits of The Baby Friendly Hospital Initiative In A Second Care Hospital In México

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Healthcare And Societal Burden of Friedreich’s Ataxia In The United Kingdom

    Nov 1, 2016, 00:00

  • Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in Fran Next Generation Sequencing

    Nov 1, 2016, 00:00

  • Health Resource Utilization (HRU) and Costs for Metastatic Renal Cell Carcinoma (MRCC) Patients Treated With First-Line (1l) Systemic Therapy in The United States

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden

    Nov 1, 2016, 00:00

  • Indirect Costs of Stroke in Turkey

    Nov 1, 2016, 00:00

  • The Utilization Of Selected Screening Tests In Gree A Descriptive Analysis

    Nov 1, 2016, 00:00

  • Burden of Illness for Patients with Hereditary Attr Amyloidosis with Polyneuropathy Begins with Symptom Onset and Increases with Disease Progression

    Nov 1, 2016, 00:00

  • The Economic Impact of Using Antimicrobial Catheters Impregnated with Rifampin and Clindamycin to Reduce Infection Rates in External Ventricular Drainage- A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Implementing Computed Tomography Screening for Early Diagnosis of Lung Cancer in Taiwan

    Nov 1, 2016, 00:00

  • A Simulation Model for Peripheral Arterial Disease- Methods and Application of A Markov Model

    Nov 1, 2016, 00:00

  • Theatre Efficiency and Effectiveness- NHS Trust and Industry Partnership

    Nov 1, 2016, 00:00

  • Time Trends In Sequence Of Drug Launch Across Eu5

    Nov 1, 2016, 00:00

  • Inclusion Of Costs And Effects Related To Toxicity/Safety In Cost -Effectiveness Analysis; An Illustration For Influenza Vaccines

    Nov 1, 2016, 00:00

  • Price And Utilization Of New Drugs Under A Single Public Payer System- Evidence From Taiwan

    Nov 1, 2016, 00:00

  • Elements of Orphan Drugs Value

    Nov 1, 2016, 00:00

  • Health-Related Quality Of Life (Hrqol) Based On Preferences From 14 Countries In Primary Health Care Setting (Phcs)

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Sunitinib Versus Pazopanib and Best Supportive Care for the Treatment of Metastatic Renal Cell Carcinoma in Chile

    Nov 1, 2016, 00:00

  • Health Insurance Cost of Stroke in Hungary- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of 52 Mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) Versus Short-Acting Hormonal Contraceptives In Avoiding Unintended Pregnancy (Up) In 15 To 19 Year-Old Adolescents Under The Brazilian Public Health ...

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Detoxification and Maintenance Treatment With Buprenorphine/Naloxone Combination in Turkey

    Nov 1, 2016, 00:00

  • Determening The Optimal Price For New Non-Nucleoside Reverse Transcritase Inhbitor Using Early Economic Modeling

    Nov 1, 2016, 00:00

  • Adverse Events in Relaxing Virtual Environments

    Nov 1, 2016, 00:00

  • Prevalence of Potentially Inappropriate Prescribing in Central Nervous System and Psychotropic Drugs for the Korean Elderly- A Cross-Sectional Study Using the National Health Insurance Claims Database

    Nov 1, 2016, 00:00

  • Prevalence of Comorbidities and Health Status among Current Cancer and Cancer Survivors- An Australian Population-Based Study

    Nov 1, 2016, 00:00

  • Excess Costs of Panic Disorder with or without Agoraphobia in Germany - The Application of Entropy Balancing to Multiple Imputed Datasets

    Nov 1, 2016, 00:00

  • A Cost-effectiveness Analysis of Pharmacokinetic (Pk) Driven Prophylaxis VS. Standard Prophylaxis In Haemophilia A

    Nov 1, 2016, 00:00

  • Cost-Utility of In-Ambulance Telemedicine for Stroke Patients

    Nov 1, 2016, 00:00

  • Collecting Data To Enable Innovative Pricing Approaches

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Restricted Protein Diet In Patients With Phenylketonuria In The Czech Republic

    Nov 1, 2016, 00:00

  • Don't Put Off Until Tomorrow What You Can Do Today- Cost-Effectiveness of Trastuzumab Plus Paclitaxel Combination Therapy and Sequential use of Paclitaxel and Trastuzumab in the Treatment of Metastatic Breast Cancer in Singapore

    Nov 1, 2016, 00:00

  • Burden of Congenital Hyperinsulinism In The United Kingdom- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns with Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease in Israel

    Nov 1, 2016, 00:00

  • Copd Uncovered- Health Care Resource Use and Cost of Chronic Obstructive Pulmonary Disease in Japan

    Nov 1, 2016, 00:00

  • COPD Drugs In Europe - A Comparison of Market Access Decisions In France, Germany, Sweden and UK with The Prismaccess Database

    Nov 1, 2016, 00:00

  • An Australian National Cost of Illness Study For Hereditary Haemochromatosis

    Nov 1, 2016, 00:00

  • Cardiovascular Drug Utilisation in Slovakia, Main Regional Characteristics

    Nov 1, 2016, 00:00

  • Indirect Costs Of Epilepsy In Turkey- Cost Of The Disease In Terms Of Work Loss

    Nov 1, 2016, 00:00

  • Institute for Clinical and Economic Review (ICER) VS. Health Technology Assessment (HTA) Agencies- The Case of Multiple Myeloma and PCSK9S

    Nov 1, 2016, 00:00

  • Review of Data Cuts used as Basis for Statistical Analyses and Derivation of Additional Benefit Presented within German Benefit Assessments for Oncological Drugs

    Nov 1, 2016, 00:00

  • Expected Impact of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) on Health Technology Assessment

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of The Use Of Infliximab Biosimilar Inflectra In Rheumatoid Arthritis, Psoriatic Arthropathy And Ankylosing Spondylitis Patients

    Nov 1, 2016, 00:00

  • Social Return on Investment in Psoriasis

    Nov 1, 2016, 00:00

  • What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis

    Nov 1, 2016, 00:00

  • To Diagnosis Embryonic Developmental Anomalies of Genetic Origin with Exome Sequencing- A Discrete Choice Experiment to Assess Parents’ Preferences for Disclosure of Findings and Support

    Nov 1, 2016, 00:00

  • Comparative Analysis on The Out-Of-Pocket Expenditure Among Patients Suffering From Chronic Kidney Disease between Medical Insurance Covered And Uncovered Areas in China

    Nov 1, 2016, 00:00

  • HTA On Role of Chitosan In Hemostasis

    Nov 1, 2016, 00:00

  • What is The Level of Transparency in Health Technology Assessment Process in Hungary, Romania and Turkey?

    Nov 1, 2016, 00:00

  • Budget Impact of Bronchial Thermoplasty In Patients with Uncontrolled Severe Asthma

    Nov 1, 2016, 00:00

  • The Validity of Markov Model for the Prognostic Estimation of Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Antiviral Activity and Embryonic Toxicity of Moxidectin Against Influenza Virus H9

    Nov 1, 2016, 00:00

  • Differences in Long-Term Patient Outcomes with Disease-Modifying Versus Symptomatic Treatments for Alzheimer’s Disease (Ad)

    Nov 1, 2016, 00:00

  • Hypertension Is Associated With Worse Outcomes Among Hospitalized Children With Autosomal Dominant Polycystic Kidney Disease In The US

    Nov 1, 2016, 00:00

  • Impact of Empagliflozin (Jardiance) to the NHS- Estimation of Budget and Event Impact Based on Empa-Reg Outcome Data

    Nov 1, 2016, 00:00

  • The Shift From A Compassionate Drug Use To The Common Market–Access Process- An Inflationary No Man’s Land?

    Nov 1, 2016, 00:00

  • The Health Economic Impact of Managing CMPA According To Guidelines- Challenging Current Treatment Practise In The UK

    Nov 1, 2016, 00:00

  • Building Intentions with the Theory of Planned Behaviour- The Mediating Role of Knowledge and Expectations in Implementing New Pharmaceutical Services in Malaysia

    Nov 1, 2016, 00:00

  • Implementation of Medication Errors Reporting System by Clinical Pharmacists at Tertiary Care Teaching Hospital- A Pilot Study

    Nov 1, 2016, 00:00

  • Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study

    Nov 1, 2016, 00:00

  • Behavior of Vas Measures of Patient Satisfaction with Remote Monitoring of Cardiac Implantable electronic devices. The valiosa questionnaire

    Nov 1, 2016, 00:00

  • Multiple Sclerosis- Real-World Healthcare Costs In A Large US Health Plan

    Nov 1, 2016, 00:00

  • community Residents' Knowledge and Attitudes Towards Antibiotics in Penang, Malaysia- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Self-Reported Sleep Quality, Duration And Health-Related Quality Of Life In Older Chinese

    Nov 1, 2016, 00:00

  • The Impact of Psoriasis Vulgaris on Health Related Quality of Life In Greece

    Nov 1, 2016, 00:00

  • Applying for Apheresis Treatment in Germany – Regional Differences Over 5 Years (2010-2014)

    Nov 1, 2016, 00:00

  • Assessment of Race-Specific Tolerability And Effectiveness of Exenatide once-Weekly or Basal Insulin Among Patients With Type 2 Diabetes In A Real World Setting In The USA

    Nov 1, 2016, 00:00

  • Cost-Effectivness Analysis of Axitinib In The Treatment of Metastatic Renal Cell Carcinoma – Clinical Data Vs RWE

    Nov 1, 2016, 00:00

  • Direct Cost Estimation of Psoriasis Treatment in Turkey- Results from a Delphi Panel

    Nov 1, 2016, 00:00

  • Incidence of Febuxostat and Allopurinol-Induced Cutaneous Adverse Reaction- A Hospital Based Cohort Study

    Nov 1, 2016, 00:00

  • Investigating The Perceptions Of The Greek Population Towards The Efficacy And Safety Of Generic Drugs

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece

    Nov 1, 2016, 00:00

  • A Review of the Use of Network Meta-Analysis In Nice Single Technology Appraisals

    Nov 1, 2016, 00:00

  • Effectiveness of Identifying A Cancer Patient In The Hospital Sector In Northern-Norway - Analyses Based on Regional Performance Database

    Nov 1, 2016, 00:00

  • Are Drug Procurement Procedure and Award Criteria in EU Hospital Setting Standardized and do they Take into Accounts Effective Supply Quality?

    Nov 1, 2016, 00:00

  • A Case Study on the Development, Implementation and Outcome of Critical Disease Insurance in Shen Zhen, China

    Nov 1, 2016, 00:00

  • Assessment of Channelling Bias Among Initiators of Glucose Lowering Drugs - A Cohort Study

    Nov 1, 2016, 00:00

  • Evaluating the Quality of Evidence From the Aspire and Endeavor Clinical Trials Using the Grading of Recommendations, Assessment, Development and Evaluation (Grade) Approach

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Daclizumab Versus Fingolimod In The Treatment Of Patients With Relapsing-Remitting Multiple Sclerosis In Norway

    Nov 1, 2016, 00:00

  • Ethical and Technological Evaluation of Security of Connected Objects and Health Applications- How to Move Towards Certification

    Nov 1, 2016, 00:00

  • Comparing the Hospitalization and Rehospitalization Expenditures of Myocardial Infarction Patients in Beijing, 2012-2013

    Nov 1, 2016, 00:00

  • Gender-Specific Patterns of Productivity Loss in Colorectal Cancer Survivors in a Multi-Ethnic Asian Population

    Nov 1, 2016, 00:00

  • Timeline of Authorization and Reimbursement for Oncological Drugs in Italy- An Integrated Analysis, Across Legislation’s Leverage

    Nov 1, 2016, 00:00

  • Bevacizumab in The Treatment of Kras Wild Type Metastatic Colorectal Cancer- An Economic Analysis Based on The Calgb 80405 Trial

    Nov 1, 2016, 00:00

  • Is There a Threshold in France?- First Exhaustive Review of Published Health-Economic Appraisals by the Haute Autorite De Sante (HAS), (French National Authority for Health)

    Nov 1, 2016, 00:00

  • How Real Is “Free Pricing” In The Uk?

    Nov 1, 2016, 00:00

  • The Effect of Depression on Adherence To Hormone Therapy in Breast Cancer Patients

    Nov 1, 2016, 00:00

  • Review of the Recommendations Made by the National Institute for Health and Care Excellence (NICE) and the Scottish Medicial Consortium (SMC) Relating to Treatments for Rare Diseases

    Nov 1, 2016, 00:00

  • Delays In Breast Cancer Diagnosis And Initiation of Treatment- Implementing The Pathways To Treatment Model In The Greek Setting

    Nov 1, 2016, 00:00

  • Descriptive Analysis of the Resected Pancreatic Cancer Patient Journey- Findings from a U.S. Real-World Claims-Based Analysis

    Nov 1, 2016, 00:00

  • Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Introducing Pharmacist-Managed Warfarin Service In The Republic of Serbia

    Nov 1, 2016, 00:00

  • Epidemiological Profile of Knee Arthroplasty Surgery in Health Care System of Public Employees Located in Northeast Brazil Between July 2014 and December 2015

    Nov 1, 2016, 00:00

  • Correlation Between Tea Consumption and Prevalence of Hypertension Among Singaporean Chinese Residents Over 40

    Nov 1, 2016, 00:00

  • Sensitivity Analysis of Antibiotic Cost in Chronic Suppurative Otitis Media Patients In South India- A Retrospective Observational Study

    Nov 1, 2016, 00:00

  • Clinical Outcome and Health Care Costs of Blood Stream Infections with Resistant Klebsiella Pneumoniae in Pediatric Patients

    Nov 1, 2016, 00:00

  • Risk Sharing Agreements (RSA)- Exploratory Analysis of the Current Situation in Developed and Emerging Markets

    Nov 1, 2016, 00:00

  • Domestic Manufacturing In Russia- Measuring The Success Of The Pharma 2020 Program

    Nov 1, 2016, 00:00

  • Prevalence of Low Birthweight and its Correlates from 2008 to 2014 in Xindu County of Chengdu, China

    Nov 1, 2016, 00:00

  • Comparison of Economic Evaluation Guidelines Between Japan and other Countries

    Nov 1, 2016, 00:00

  • Pharmaceutical Policies In Eurasian Economic Union Countries

    Nov 1, 2016, 00:00

  • Quantification Of Patient Preference Analysis- Wearing The Federal Joint Committee Lens To Assess Evidence

    Nov 1, 2016, 00:00

  • The Clinical Value of Olmesartan for the Treatment of Hypertensive Patients- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution And Tobramycin Dry Powder For Inhalation In Cystic Fibrosis Patients In Sweden

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Threshold in Cancer Therapy – is This A Good Idea?

    Nov 1, 2016, 00:00

  • Optimising Adverts And Campaigns For Efficient And Cost-Effective Patient Recruitment Using Social Media

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Blue-Light Therapy Vs Fixed Combination of Calcipotriol and Betamethasone Dipropionate Gel in the Treatment of Mild-To-Moderate Psoriasis

    Nov 1, 2016, 00:00

  • Non-Parametric Approach to Estimating Expected Value of Perfect Information- The Usefulness of this Approach to a National HTA Agency

    Nov 1, 2016, 00:00

  • The Potential Budget Impact of PCSK9 Inhibitors in Ireland

    Nov 1, 2016, 00:00

  • The Burden Associated with Intra-Operative Anastomotic Leaks in Colorectal Surgery

    Nov 1, 2016, 00:00

  • Progression and Outcomes of Non-Dialysis Dependent Chronic Kidney Disease Patients

    Nov 1, 2016, 00:00

  • Real World Anaplastic Lymphoma Kinase (ALK) Rearrangement Testing Patterns, Treatment Sequences and Survival of ALK-Inhibitor Treated Patients

    Nov 1, 2016, 00:00

  • Cost Of Illness Of Partial Onset Seizures Epilepsy In Italy- Results From The Prometeo Study

    Nov 1, 2016, 00:00

  • A Critical Review of Medication Review Tools for Long-Term Care Facilities and Development of a Novel Tool for Qatar

    Nov 1, 2016, 00:00

  • Valuation of EQ-5D-5L Health States- A Comparison of Three Asian Countries

    Nov 1, 2016, 00:00

  • Reform of Chinese State-Owned Enterprise-Affiliated Hospital

    Nov 1, 2016, 00:00

  • Improving Patients Quality of Life By Valuation of Patient Satisfaction with Specific Characteristics of Medical Devices For Urinary Incontinence

    Nov 1, 2016, 00:00

  • A Decision-Focused Network Meta-Analysis (NMA) of Dipeptidyl Peptidase-4 (DPP4) Inhibitors Used In Combination With Metformin And A Sulfonylurea For The Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Health State Utility Values (Hsuvs) Measured Using The Euroqol 5-Dimensions (Eq-5d) Questionnaire In Adults With Chronic Hepatitis C (Chc)- A Systematic Literature Review (Slr)

    Nov 1, 2016, 00:00

  • Bilirubin and Neurodegenerative Disease Prevention

    Nov 1, 2016, 00:00

  • Rapid, Comprehensive Oral Nutritional Supplement Quality Improvement Program Reduces Length Of Stay In Malnourished Hospitalized Patients

    Nov 1, 2016, 00:00

  • Value And Cost Conundrum In Advanced Oncology- Integration Of Value Frameworks Into Cost-Effectiveness Analyes

    Nov 1, 2016, 00:00

  • Incidence of Germline Brca 1 and 2 Mutated Breast Cancer in The EU5

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rituximab in the Treatment of Diffuse Large B-Cell Non-Hodgkin's Lyphoma Patients (Dlbcl) in China

    Nov 1, 2016, 00:00

  • Comparative Safety and effectiveness of Carbapenems Versus Alternative Antibiotics for Bacteraemia due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Validation of A Novel Tool To Predict Outcomes in Patients with Nosocomial Pneumonia

    Nov 1, 2016, 00:00

  • clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Nov 1, 2016, 00:00

  • The Implications of Parameter Independence in Probabilistic Sensitivity Analysis

    Nov 1, 2016, 00:00

  • Assessing The Consequences Of Sustained Off-Therapy Hbsag Loss In Health Economic Models Of Chronic Hepatitis B; A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Impact of Cardiovascular Outcome Trial (CVOT) Data on EU5 Access for New Type 2 Diabetes Drugs

    Nov 1, 2016, 00:00

  • Pretesting An E-Based Version Of The Oxford Participation Activities Questionnaire (Ox-Paq)

    Nov 1, 2016, 00:00

  • Patient-Reported Need vs. Concern Around Injectable Therapy and Impact on Adheren A Real-World Survey of 5EU/US T2DM Patients

    Nov 1, 2016, 00:00

  • Structure of HTA Networks From The Perspective of Network Economics

    Nov 1, 2016, 00:00

  • Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)

    Nov 1, 2016, 00:00

  • Creating Useful and Comprehensive Decision Support Tools for Selecting and Designing Managed Entry Agreements

    Nov 1, 2016, 00:00

  • Online Pharmacy Regulation in India- A Cross Sectional Survey on Perceptions of Health Care Students/Professionals

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Triveram for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00

  • Optimizing COPD Treatment In Portugal – Improving Health Outcomes And Reducing Treatment Costs In Patients with A History of Exacerbation with Indacatrol Plus Glycopyrronium

    Nov 1, 2016, 00:00

  • Identifying Patient Reported Signs and Symptoms of Being Overweight and Obese

    Nov 1, 2016, 00:00

  • Disease Activity, Quality of Life And Indirect Costs Associated With Ulcerative Colitis In Poland

    Nov 1, 2016, 00:00

  • Economic Burden Associated with Chronic Myeloid Leukemia (CML) Treatments in The United States- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Delayed Access To Bariatric Surgery In Brazil- Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Title- Access to Orphan and Ultra-Orphan Drugs in China

    Nov 1, 2016, 00:00

  • Network Analysis Approach To Explore Sponsor Involvement In Clinical Trials

    Nov 1, 2016, 00:00

  • Work Productivity/Interference and General Health Status Improvements with Sirukumab, an Anti-Il-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs- Res ...

    Nov 1, 2016, 00:00

  • Taking In Account Research And Development Expenditures To Determine Prices Of Medicines In Fran A Realistic Alternative Choice?

    Nov 1, 2016, 00:00

  • Does The Trend Towards Value Frameworks Require New Approaches to Evidence Development and Health Technology Assessment?

    Nov 1, 2016, 00:00

  • Azacitidine for Treating Acute Myeloid Leukaemia- A Nice Single Technology Appraisal

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Long-Term Versus Short-Term Dual Antiplatelet Therapy in Patients with Drug-Eluting Stents

    Nov 1, 2016, 00:00

  • Network Meta-Analysis of Antidiabetic Treatments Added To Insulin Therapy In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Assessment of Health Related Quality of Life (Hrqol) of Patients with Severe Mental Illness Attending Tertiary Care Public Hospitals of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Seasonal Variations of Outpatient Antibiotic use in Austria

    Nov 1, 2016, 00:00

  • Determination Of Clinical And Cost-Effectiveness Of Various Methods Of Predicting Preterm Birth In Women With High Risk

    Nov 1, 2016, 00:00

  • Generalising Results from Cost-Effectiveness Analysis- A Comparison of Methods to Account for Covariates

    Nov 1, 2016, 00:00

  • Predictors of Disease Progression in Mild Alzheimer’s Disease Dementia Patients – Results From the Geras Real World Cohort and Expedition Trials

    Nov 1, 2016, 00:00

  • Health Technology Assessment Decisions for Novel Psoriasis and Psoriatic Arthritis Agents- Results, Rationale, and Trends

    Nov 1, 2016, 00:00

  • A Qualitative Study Exploring Perception and Attitudes of Community Pharmacists About Extended Pharmacy Services in Lahore, Pakistan

    Nov 1, 2016, 00:00

  • Real World Experience of Sunitinib in Patients with Metastatic Renal Cell Carcinoma; Results from Compassionate use Program in Malaysia

    Nov 1, 2016, 00:00

  • Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia

    Nov 1, 2016, 00:00

  • Linguistic Validation of the Finnish Version of the Body-Q Pro Instrument

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Evaluation of Cancer Treatments in India

    Nov 1, 2016, 00:00

  • Cadth’s $50,000 Cost-Effectiveness Threshold- Fact or Fiction?

    Nov 1, 2016, 00:00

  • A Comparison of Insulin Degludec Clinical Evaluations and Recommendations Between an Independent HTA and National HTA Bodies

    Nov 1, 2016, 00:00

  • A Synopsis on Opportunities and Challenges of Patient Related Outcome Measures (PROMS) for Patient Benefits

    Nov 1, 2016, 00:00

  • Role of Genetic Variation in Type Repeats of Histidine Rich Protein-2 Gene in Altering the Performance of Malaria Rapid Detection Kit in Global Context

    Nov 1, 2016, 00:00

  • Improving Patients Quality of Life By Valuation of Patient Satisfaction With Specific Characteristics of Rehabilitation Medical Devices - Weight, Fit, Appearance, Comfort, Pain Free, Free of Abrasiveness, Ease of Application And Durability

    Nov 1, 2016, 00:00

  • Effects of A Chronic Obstructive Pulmonary Disease Integrated Care Pathway Programme in Singapore

    Nov 1, 2016, 00:00

  • A Population-Based Cohort of Gaucher Disease Patients Identified Using EHR Data

    Nov 1, 2016, 00:00

  • Factors Affecting Pharmaceutical Expenditures- A Systematic Review

    Nov 1, 2016, 00:00

  • Utilization of Antimicrobial Agents at the Haematology Ward in a Public Hospital

    Nov 1, 2016, 00:00

  • Cost–Effectiveness of Different Strategies for Prevention of Venous Thromboembolism after Total Hip Replacement in China

    Nov 1, 2016, 00:00

  • New Legislative Pathway of Turkey for Assessing Reimbursement Applicatons of Medical Devices

    Nov 1, 2016, 00:00

  • The Burden of Illness in Patients with Castrate-Resistant Prostate Cancer with Bone Metastases in Asia Pacific (Australia, South Korea, and Taiwan)

    Nov 1, 2016, 00:00

  • Impact of Glucosamin and Chondroitin Sulfates Combination (GCSC) on the Burden of Osteorthritis over 6 Months in Portugal- An Observational Study

    Nov 1, 2016, 00:00

  • Comparison Between Eq-5d And Hui In Japanese Population Norms

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Different Cervical Cancer Primary Screening Using Cytology, HPV Or P16/KI-67 Testing Alone Or in Combinations for The Austrian Health Care Context

    Nov 1, 2016, 00:00

  • Do Scottish Formulary Decisions Match Recommendations Made By The Smc?

    Nov 1, 2016, 00:00

  • Reconstruction Of Major Lower-Extremity Amputation Stump With A Free Latissimus Dorsi Flap

    Nov 1, 2016, 00:00

  • Hospital Admissions and Inpatient Costs of Non-Union, Delayed Union and Mal-Union Following Long Bone Fracture

    Nov 1, 2016, 00:00

  • Use Of Surveillance Databases To Describe Influenza Epidemiology In Europe

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in England and Scotland- Applying Real-World Evidence to Enhance Generalisability to A UK Population

    Nov 1, 2016, 00:00

  • The Impact of Community Pharmacies (CP) On Regional Equity In The Access To The Portuguese Needle And Exchange Programme (NEP)

    Nov 1, 2016, 00:00

  • Influence of Air Pollution on Some Pregnancy Outcomes and Burden of Pneumonia on Children Under Five Years Old in Mongolia

    Nov 1, 2016, 00:00

  • Cost-Effective Analysis Of The Dengue Vaccine In Costa Rica

    Nov 1, 2016, 00:00

  • The Impact of Underusing Lipid-Lowering Medications on the Risk of Heart Attack and Hospitalizations in United States Elderly Population

    Nov 1, 2016, 00:00

  • Budget Impact Analysis for Intracameral Injectable Solution Combining Two Mydriatics and One Anaesthetic for Cataract Surgery

    Nov 1, 2016, 00:00

  • How do Cost-Containment Measures Impact Pharmaceutical Industry?

    Nov 1, 2016, 00:00

  • Social Preferences for Rare Diseases in Spain

    Nov 1, 2016, 00:00

  • Productivity Loss of Cancer Patients in Japan

    Nov 1, 2016, 00:00

  • Clinical And Econimic Burden Of Community-Onset Complicated Skin And Skin Structure Infection (Csssi) In Korea

    Nov 1, 2016, 00:00

  • Assessment of Knowledge, Attitude and Barriers Towards ADRS Reporting Among Healthcare Professionals of Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Screening Program

    Nov 1, 2016, 00:00

  • The impact of Local Skin Reactions (LSRS) on Resource Use and Quality of Life Associated with Different Field Therapies for Actinic Keratosis. Results from a Belgian Expert Survey

    Nov 1, 2016, 00:00

  • Demographic and Clinical Characteristics of Migraine Patients in Denmark

    Nov 1, 2016, 00:00

  • Cost of Switching From An Originator Biologic (Remicade) To A Biosimilar

    Nov 1, 2016, 00:00

  • An International Patient Survey on Health Related Quality of Life Aspects not Cpatured by EQ-5D-5L

    Nov 1, 2016, 00:00

  • Pegaspargase In The Treatment of Acute Lymphoblastic Leukemia- A CMA Model Demonstrates Its Economic Benefit For The Italian National Health System

    Nov 1, 2016, 00:00

  • Mapping of The Gastrointestinal Short Form Questionnaire (GSFQ) into SF-6D and EQ-5D in Spanish Population

    Nov 1, 2016, 00:00

  • The Budget Impact Analysis of Thrombopoietin Receptor Agonists For The Treatment of Idiopathic Thrombocytopenic Purpura In Adults

    Nov 1, 2016, 00:00

  • Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in Spain- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Clinical Profile and Management of Chronic Kidney Disease in Indian Geriatric Patients at a Public Tertiary Care Hospital- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Development of An Economic Model To Assess The Cost-Effectiveness of Nitisinone As A Treatment For Alkaptonuria In The UK

    Nov 1, 2016, 00:00

  • Real-World Evidence in the Context of Hta- On the Example of Uterine Fibroids Treatment in Ukraine

    Nov 1, 2016, 00:00

  • A Review Evaluating the Validity of Motion-Based Gaming Platforms to Measure Clinical Outcomes in Clinical Research

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in Alternative Age Groups

    Nov 1, 2016, 00:00

  • Reweighting Rct Evidence To Better Reflect Real Life- A Case Study of The Innovation Medicines Initiative

    Nov 1, 2016, 00:00

  • Variations in Stakeholder Preferences between Innovative Pricing Agreement Types Across the EU5

    Nov 1, 2016, 00:00
  • «
  • 81
  • 82
  • 83
  • 84 (current)
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »